본문으로 이동


A Brief History

Korean Pharmaceutical Innovators' Group
Korea Drug Research Association

내 페이스북 계정에 현재 페이지 등록하기 트윗터에 공유하기 현재 페이지 URL 복사

2010~2013

  • 2013
    2013. 4. 10
    Approval of the modification of the bylaws (research community support part of the Ministry of Science, ICT and Future Planning)
    2013. 2. 28
    Dong-Yeon Kim assumed the position as the 13th chairman of the board.
  • 2012
    2012. 6. 1
    Selected as the managing department for the research plan of “IMD development research with low molecular weight for complex and technology-based formulation for circulatory disease treatment to advance into the global market” by the source technology development fused with industry business by the Ministry of Knowledge Economy.
    2012. 3. 13
    Signboard hanging ceremony for the research groups under the Korea Drug Research Association.
    - Korea Pharmaceutical Advanced-development Committee (RA Committee of Regulatory Affairs Professionals)
    - Korea Association of Pharmaceutical Ingredients
    - Korea Association of Research Pharmaceutical Analysis
    - Korea Association of Herbal Medicinal Products
    - Molecular Design Research Group
  • 2011
    2011. 9. 23
    Launch of the Korea Association of Herbal Medicinal Products under the Korea Drug Research Association.
    2011. 5. 3
    Relocation of the main association office (1st Floor of the Korean National Tuberculosis Association Building, 121-150, Dangsan-dong, Yeongdeungpo-gu, Seoul, Korea).
  • 2010
    2010. 9. 8
    Launch of the Molecular Design Research Group under the Korea Drug Research Association.
    2010. 6. 4
    Innovation Policy Research Center (INNOPOL) was established under the Korea Drug Research Association.
    2010. 2. 17
    Launch of the technology officer forum for the pharmaceutical industry / bio industry under the Korea Drug Research Association.

2000~2009

  • 2008
    2008. 6. 12
    Launch of the Korea Association of Research Pharmaceutical Analysis under the Korea Drug Research Association.
  • 2007
    2007. 2. 27
    Eui-Hwan Cho continues as the 10th chairman of the board.
  • 2006
    2006. 2. 15
    Launch of the Committee of Regulatory Affairs Professionals (CoRAPs) under the Korea Drug Research Association.
  • 2005
    2005. 7. 1
    Selected as the managing department for the research plan of “Development of next-generation drugs using glycomics” by the new technology of the next-generation technology development business of the Ministry of Commerce, Industry, and Energy.
    2005. 4. 30
    Selected as the managing department for the research plan of “Measures of competitiveness for the preparation of macroscopic (Red) BT-TRM and our company (Red) BT” by the policy research service business of the Ministry of Commerce, Industry, and Energy.
  • 2004
    2004. 9. 1
    Selected as the managing department for the research plan of “Synthetic drug development technology for incurable disease treatment through cell signal control” by the new technology of the next-generation technology development business of the Ministry of Commerce, Industry, and Energy.
    2004. 4. 26
    Selected as the managing department for the research development business “Synthetic drug technology development of intractable and chronic disease treatment of the next generation” by the industry analysis research development business of the Ministry of Commerce, Industry, and Energy.
    2004. 2. 27
    Eui-Hwan Cho assumed the position as the 9th Chairman of the board.
  • 2003
    2003. 6. 1
    Selected as the service agency for the “Preparation of the industrial technology road map for gene therapy” by the Ministry of Commerce, Industry, and Energy.
    2003. 4. 30
    Resignation of President Seon-Jin Kim (CEO of Yuhan corporation) and appointment as a consultant.
    Eui-Hwan Cho assumed the position as the 8th chairman of the board.
  • 2001
    2001. 7. 1
    Selected as the service agency for the “Preparation of the industrial technology road-map for fine biological chemistry activity” by the Ministry of Commerce, Industry, and Energy.
    2001. 2. 26
    Seon-Jin Kim (CEO of Yuhan Corporation) continues as the 7th chairman of the board.
    2001. 2. 10
    Foundation of “The Bioview” (monthly) (ISSN 1598-088X).
    2000. 5. 30
    Establishment of PharmaTech Business Center (PTBC) under the Korea Drug Research Association.

1990~1999

  • 1999
    1999. 4. 29
    Enactment of Korea New Drug Award
    * Sponsors: Ministry of Health and Welfare, Ministry of Science and Technology, Ministry of Commerce, Industry, and Energy, and Maeil Business Newspaper/TV
    1999. 4. 19
    Selected as the managing department for the research plan of “Technology development for liver cancer and liver disease treatment” by the next-generation technology development business of the Ministry of Commerce, Industry, and Energy.
    1999. 2. 23
    Resignation of President Seong-Ki Lim (President of Hanmi Pharma.) and appointment as a consultant.
    Seon-Jin Kim (CEO of Yuhan Corporation) assumed the position as the 6th Chairman of the board.
    1999. 1. 1
    Foundation of the Internet News Focus.
  • 1998
    1998. 12. 23
    Selected as the “Innovative drug development technique agency” by the health and medical treatment technology development business of the Ministry of Health and Welfare.
    1998. 11. 30
    Selected as the “New drug commercializing agency” by the major country research development business of the Ministry of Science and Technology.
    1998. 10. 22
    Selected as the managing department for the research plan of “Pharmaceutical intermediates and original production technique development for optically active molecules” by the midterm technology development business of the Ministry of Commerce, Industry, and Energy.
    1998. 2. 25
    Seong-Ki Lim (President of JW Pharmaceutical) continues as the 5th chairman of the board.
  • 1997
    1997. 9. 1
    Selected as the managing department for the research plan of “Pharmaceutical intermediates and original production technique development for optically active molecules” by the midterm technology development business of the Ministry of Commerce, Industry, and Energy.
  • 1996
    1996. 12. 28
    Kang-Chu Lee assumed as a full-time director.
  • 1995
    1995. 2. 28
    Seong-Ki Lim (President of Hanmi Pharma.) continues as the 4th chairman of the board.
  • 1994
    1994. 9. 1
    Launch of the pharmaceutical intermediates/pharmaceutical ingredient development research association under the Korea Drug Research Association.
    1994. 2. 23
    Establishment of royalty management rules.
  • 1993
    1993. 12. 20
    Selected as the managing department for the research plan of the Central R & D business, “High-functioning medicine business with technological innovation in the manufacturing process”, by the Ministry of Science and Technology.
    1993. 7. 30
    Selected as the managing department for the research plan of the central R & D medicine demonstration business by the Ministry of Science and Technology.
    1993. 2. 17
    Foundation of “New Drug Newsletter” (monthly).
  • 1992
    1992. 12. 22
    Planning Steering Committee launched.
    1992. 6. 26
    Relocation of the main association office (474-15, Bangbae 2-dong, Seocho-gu, Seoul, Korea).
    1992. 2. 13
    Resignation of President Jong-Ho Lee (President of JW Pharmaceutical) and appointment as a consultant.
    * Seong-Ki Lim (President of Hanmi Pharma.) assumed the position as the 3rd chairman of the board.
  • 1991
    1991. 12. 21
    Selected as the managing department for the research plan for “G7 project of product technology development on new drug / new pesticide” by the Ministry of Science and Technology.
    1991. 7. 5
    Contract concluded with Otsuka Pharmaceuticals for regular training dispatch.
    1991. 6. 1
    Foundation of “R & D Infosheet” (monthly).

1986~1989

  • 1989
    1989. 2. 24
    Jong-Ho Lee (President of JW Pharmaceutical) continues as the 2nd chairman of the board.
  • 1987
    1987. 6. 29
    Corporate change approval according to the Industrial Technology Research Association Support Act (Ministry of Science and Technology).
  • 1986
    1986. 8. 13
    Approval of the Korea Drug Research Association establishment (Corporation / Special corporation) (Ministry of Science and Technology).
    * Federation of Korean Industries Head Office Building, Yeouido-dong, Yeongdeungpo-gu, Seoul, Korea
    1986. 5. 26
    Inaugural assembly held for the Korea Drug Research Association (corporation) under the Ministry of Science and Technology.
    * Jong-Ho Lee (President of JW Pharmaceutical) assumed the position as 1st chairman of the board.
    1986. 5. 15
    (Tentative) Organizing committee held for the Korea Drug Research Association Corporation.

본문 상단으로 이동


Korea Drug Research Assocoation
Address : 24, Beodeunaru-ro 14ga-gil, Yeongdeungpo-gu, Seoul, Korea (07230), Tel. : +82-2-525-3106, Fax. : +82-2-525-3109, E-Mail : kdra@kdra.or.kr, Website : http://www.kdra.or.kr Copyright © Korea Drug Research Assocoation (KDRA). All Rights Reserved.
X
Submission Check (Login)

※ Korea Drug Research Assocoation 회원님께서는 로그인 하세요.

아이디 비밀번호